banner
Pawg khoom
Tiv tauj peb

Hu rau:Errol Zhou (Mr.)

Tel: ntxiv 86-551-65523315

Mobile/WhatsApp: ntxiv 86 17705606359

QQ:196299583

Skype:lucytoday@hotmail.com

Email:sales@homesunshinepharma.com

Ntxiv:1002, Huanmao Tsev, No.105, Mengcheng Txoj kev, Hefei Lub zos, 230061 Tuam Tshoj

APIs thiab Intermediates
Doxazosin Mesylate CAS 77883-43-3

Doxazosin Mesylate CAS 77883-43-3

CAS TSIS TAU: 77883-43-3
Cov mis mos molecular: C24H29N5O8S
Molecular phaus: 547.58100
EINECS TSIS YOG: 616-536-9
MDL TSIS YOG: MFCD00216023

Txhawb tshuaj

Khoom Piav Qhia:

Khoom Lub Npe: Doxazosin mesylate CAS TSIS TAU: 77883-43-3

Lub ntsiab lus:

Doxazosin Mesylate;

[4- (4-amino-6,7-dimethoxyquinazolin-2-yl) piperazin-1-yl]-(2,3-dihydro-1,4-benzodioxin-3-yl) methanone, methanesulfonic acid;

Tshuaj& Lub Cev Muaj Zog:

Tshwm sim: Dawb mus rau dawb-dawb crystalline hmoov

Kev Ntsuas: ≥99.00%

Kub Point: 718 ℃ ntawm 760 mmHg

Melting Point: 275-277 ℃

Flash Point: 388 ℃

Kev ruaj ntseg: Tiv thaiv los ntawm lub teeb

Kev Cia Cia: Desiccate ntawm RT

Solubility: Soluble me ntsis hauv dej, sib tov sib xyaw ntawm 15 ntim dej thiab 35 tetrahydrofuran tag nrho, me ntsis yaj hauv methanol, siv tsis tau yaj hauv acetone. Nws qhia txog polymorphism (5.9), qee cov ntawv yuav yog hygroscopic

Cov Ntaub Ntawv Kev Nyab Xeeb:

Cov Lus Hais Txog Kev Nyab Xeeb: S26; S36/37

Cov Lus Qhia Risk: R36/37/38

WGK Lub Tebchaws Yelemees: 2

RTECS: TK8044000

HS Code: 29349990

Tus lej phom sij: Xi

Doxazosin yog xaiv α1-adrenoceptor antagonist. Doxazosin so cov leeg nqaij ntawm cov prostate. Doxazosin mesylate yog quinazoline compound uas yog xaiv cov inhibitor ntawm alpha1 subtype ntawm alpha adrenergic receptors. Cov tshuaj lom npe ntawm doxazosin mesylate yog 1- (4-amino-6,7-dimethoxy-2-quinazolinyl) -4- (1,4-benzodioxan-2-ylcarbonyl) piperazine methanesulfonate.Lub tswv yim siv rau doxazosin mesylate yog C23H25N505 • CH4O3S thiab qhov hnyav hnyav yog 547.6.

Doxazosin mesylate yog dawb soluble hauv dimethylsulfoxide, soluble hauv dimethylformamide, me ntsis soluble hauv methanol, ethanol, thiab dej (0.8% ntawm 25 ° C), thiab me ntsis soluble hauv acetone thiab methylene chloride. Txhua lub ntsiav tshuaj doxazosin mesylate, rau kev tswj hwm qhov ncauj, muaj 1 mg, 2 mg, 4 mg thiab 8 mg ntawm doxazosin ua lub hauv paus dawb.

Doxazosin mesylate yog lub cim tshiab ntawm quinazolone recept1 receptor blocker tsim los ntawm Pfizer tuam txhab (Tebchaws Asmeskas), Nws muaj ib nrab-lub neej ntev, siv nws cov teebmeem ntawm kev nthuav dav cov hlab ntshav, txo cov hlab ntshav tiv thaiv thiab txo cov ntshav siab los ntawm thaiv cov hlab ib 1 receptor. Nws xaiv thaiv cov a1 adrenergic receptor ntawm prostate du cov leeg sib xyaw, tshuaj ntsiav thiab lub zais zis caj dab, txo cov tsos mob ntawm cov neeg mob benign prostatic hyperplasia, thaum muaj kev kho kom zoo ntawm dysuria tshwm sim los ntawm yooj yim prostatic hyperplasia. Xyoo 1988, doxazosin, ua tshuaj rau kev kho ntshav siab, tau teev tseg hauv tebchaws Denmark. Xyoo 1995, Asmeskas FDA tau pom zoo nws rau kev kho mob benign prostatic hyperplasia. Xyoo 2002 Lub Cuaj Hli, Doxazosin tswj cov tshuaj tso tawm tau teev tseg hauv Suav teb, muab cov kev xaiv tshiab rau kev kho mob hauv tsev ntawm kev kho mob benign prostatic hyperplasia. Nws tau pom zoo nyob txawv teb chaws ua thawj kab tshuaj siv tshuaj tiv thaiv ntshav siab thiab kho kab mob prostate.

Yog tias koj txaus siab rau peb cov khoom lossis muaj lus nug, thov koj xav tiv tauj peb!

Cov khoom lag luam nyob rau hauv patent tau muab rau R& D lub hom phiaj nkaus xwb. Txawm li cas los xij, lub luag haujlwm zaum kawg tshwj xeeb tshaj yog nrog tus neeg yuav khoom.


Cim npe nrov: doxazosin mesylate cas 77883-43-3, tuam ntxhab, cov chaw muag khoom, lub Hoobkas, yuav, hauv Tshuag

Xa kev nug